Home
Conditions
Nasopharyngeal Neoplasms

Clinical trial condition

Nasopharyngeal Neoplasms

Explore clinical trials studying Nasopharyngeal Neoplasms. Study availability and eligibility vary by location and protocol.

25 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Nasopharyngeal Neoplasms trial results

Completed

Safety and Efficacy of CC-486 in Previously Treated Patients With Locally Advanced or Metastatic Nasopharyngeal Carcinoma

NCT02269943

Conditions: Carcinoma, DNA Virus Infections, Disease Attributes, +23 more
Locations: Winship Cancer Institute of Emory University Atlanta, Georgia, United States

University of Chicago Chicago, Illinois, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Columbia Comprehensive Cancer Care Clinic Jefferson City, Missouri, United States

View all 25 locations

View Trial Details

Completed

A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic Surgery

NCT03010813

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +33 more
Locations: Prince of Wales Hospital, The Chinese University of Hong Kong Hong Kong, China

View Trial Details

Completed

The Value of Diagnosis and Outcome Prediction in CTC for Metastatic NPC Patients

NCT02505139

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +16 more
Locations: Not specified

View Trial Details

Completed

Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma

NCT02360501

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Completed

Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents

NCT00565448

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Investigational Site Number 012001 Algiers, Algeria

Investigational Site Number 076002 Rio de Janeiro, Brazil

Investigational Site Number 076001 São Paulo, Brazil

Investigational Site Number 156005 Fuzhou, China

View all 26 locations

View Trial Details

Completed

The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT

NCT01797900

Conditions: Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms, +7 more
Locations: Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing Municipality, China

View Trial Details

Completed

Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

NCT00747799

Conditions: Disease Attributes, Head and Neck Neoplasms, Nasopharyngeal Diseases, +11 more
Locations: Cancer Center of Sun-Yat Sen University Guangzhou, Guangdong, China

View Trial Details

Completed

Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy

NCT00630149

Conditions: Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms, +7 more
Locations: Cancer Center of Sun-Yat Sen University (CCSYSU) Guangzhou, Guangdong, China

View Trial Details

Completed

Modified Vaccinia Ankara (MVA) Vaccine Study

NCT01256853

Conditions: DNA Virus Infections, Epstein-Barr Virus Infections, Head and Neck Neoplasms, +13 more
Locations: Department of Clinical Oncology, Prince of Wales Hospital Hong Kong

View Trial Details

Completed

Taxotere + Cisplatin in Nasopharyngeal Carcinoma

NCT00436293

Conditions: Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms, +7 more
Locations: Sanofi-Aventis Hong Kong

View Trial Details

Nasopharyngeal Neoplasms

Nasopharyngeal Neoplasms trial results

Related conditions